Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review
<b>Background:</b> The primary treatment of schizophrenia is pharmacotherapy with antipsychotic agents, such as risperidone and paliperidone. Population pharmacokinetic (PopPK) modelling plays a crucial role in optimising therapy by predicting of plasma concentrations, therapeutic effica...
| 發表在: | Pharmaceuticals |
|---|---|
| Main Authors: | , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
MDPI AG
2025-05-01
|
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/1424-8247/18/5/698 |
